GREENWICH, Conn., May 6, 2021 /PRNewswire/ — Ambina Partners LLC (“Ambina”), a private investment firm supporting growth-oriented middle market businesses, sold PeriGen Inc. (“PeriGen”), a leading provider of perinatal healthcare software solutions to Halma plc.
Ambina partnered with Atalaya Capital Management to invest in PeriGen in 2016, providing the capital for PeriGen to undertake a transformative acquisition of one of its key competitors. Once combined, Ambina partnered with management to drive increased market share and profitability through organic initiatives including the launch of its innovative early warning solution, Vigilance. Today, PeriGen serves over 300 hospitals in the U.S. and its solutions are deployed across ~500,000 childbirths annually.
“The Ambina team recognized the same opportunity and saw the same vision as our management team,” said Matthew Sappern, PeriGen’s CEO. “In addition to having the financial wherewithal to execute our plan, they were, more importantly, an effective collaborator and true partner as we carried out our shared vision.”
“PeriGen’s solution stood out from the beginning and working closely with an exceptional and determined management team to further gain market share has been a rewarding journey,” said Christine Blehle, a Partner at Ambina.
Ambina and PeriGen were advised on the transaction by Canaccord Genuity and Lowenstein Sandler LLP.
About PeriGen
PeriGen offers innovative perinatal software solutions that…
